MAR 31, 2016 1:45 PM PDT

Scientists Find Cure For Mysterious Flemish Disease

WRITTEN BY: Kara Marker
A painful inflammatory disease has been plaguing a Flemish family for more than three generations, and for the first time in ten years scientists have identified both the mutation responsible and a potential treatment for the disease.

The genetic disease, which affects about half of each infected person’s children, causes painful skin lesions, fevers, pain, and exhaustion. Through modern DNA sequencing technology, scientists from the University of Leuven, Belgium and the Walter and Elisa Hall Institute, Australia were finally able to shine a light on the mutation responsible for the family’s painful legacy.

The dominant mutation occurs on a gene called MEFV, a gene also responsible for an inflammatory disease called Familial Mediterranean Fever (FMF). However, patients with FMF must inherit mutations from both their mother and their father, and the disease can skip generations, leading the scientists to believe that this disease is recessive. Only a single copy of the MEFV mutation linked to the Flemish family is needed to cause the recently understood disease.

The disease occurring from the dominant mutation on MEFV is now being referred to as Pyrin Associated Autoinflammation with Neutrophilic Dermatosis (PAAND), and after their genetic sequencing information came back, scientists found the same mutation in English and French families in addition to the Flemish family.

"The PAAND mutation causes the body to respond as if there is a bacterial skin infection,” said Seth Masters, PhD, from the Walter and Elisa Hall Institute. “This leads to the skin making the inflammatory protein interleukin-1β, which causes skin lesions, fevers and pain."
 
Pyoderma injury, characteristic of PAAND

In healthy people, interleukin-β is produced when macrophages are activated during a pathogenic infection. Interleukins are cytokines that, in addition to stimulating the immune response that is responsible for the symptoms of PAAND, aids in cell proliferation, differentiation, and apoptosis (RefSeq). Although interleukin-β is essential to daily immune defense, producing the cytokine at the wrong time and for the wrong reasons can clearly wreak havoc on the body.

Along with the discovery of the disease-causing mutation came the development of a cure. Scientists were actually able to build off of an already existing drug called anakinra, used as an anti-arthritis medication.

Anakinra is the main ingredient of a drug called Kineret which is used to treat another autoimmune disease, rheumatoid arthritis . Kineret comes from a class of therapies that target interleukin receptors to block activity; in the case of rheumatoid arthritis, the activity being blocked prevents joint damage and pain (Kineretrx.com).

After administering the drug for the first time, the scientists quickly saw skin lesions clear and a full recovery from fevers and pain. A large clinical trial will soon begin for PAAND patients from the Flemish family to understand how the new treatment could have potential as a complete cure.
The study from University of Leuven, Belgium and the Walter and Elisa Hall Institute, Australia was published in the journal Science Translational Medicine. 
 

Source: The Flanders Institute for Biotechnology
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 17, 2020
Cardiology
A Heart Attack Induces Change in Cytokine Signaling in Patients
DEC 17, 2020
A Heart Attack Induces Change in Cytokine Signaling in Patients
Cellular signaling is critical for the body to coordinate everything from heart rate to not hitting yourself when you mo ...
DEC 30, 2020
Drug Discovery & Development
Llama Antibody Prevents Infection by COVID-19
DEC 30, 2020
Llama Antibody Prevents Infection by COVID-19
There's more to llamas than being livestock and hilarious companion animals. They also harbor an immune system capab ...
DEC 30, 2020
Drug Discovery & Development
Gene Therapy Cures Mice of Deafness
DEC 30, 2020
Gene Therapy Cures Mice of Deafness
Currently, around half a billion people suffer from hearing loss around the world. In about half of these cases, genetic ...
JAN 05, 2021
Cell & Molecular Biology
Brown Fat Appears to Protect Against Disease
JAN 05, 2021
Brown Fat Appears to Protect Against Disease
Not all fat is the same. White fat is what we're usually thinking of when we think of flabby tissue that stores excess c ...
JAN 12, 2021
Cardiology
SGLT2 Inhibitors Can Reduce the Cardiovascular Risk for Diabetics Being Treated with Insulin
JAN 12, 2021
SGLT2 Inhibitors Can Reduce the Cardiovascular Risk for Diabetics Being Treated with Insulin
One of the biggest problems that come alongside diabetes is the increased risk of cardiovascular disease. Treatment of d ...
JAN 18, 2021
Microbiology
Bacteria in Sediment is Likely Accelerating Greenland's Meltdown
JAN 18, 2021
Bacteria in Sediment is Likely Accelerating Greenland's Meltdown
For decades, scientists have been sounding the alarm about rising carbon dioxide levels in our planet's atmosphere, and ...
Loading Comments...